RxDoctor Payments Data

Savannah Morgan

Family · Renton, WANPI 1922582170

Payments from drug & device makers

What this record shows

This record is dominated by other: $71,653 of the $75,965 with a category attached, or 94.3%. Angiodynamics, Inc. accounts for 95.3% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $29,099 and has fallen 98.5% since, to $440 in 2025. Among family clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$75,965in general payments, 2019–2025

Across 101 payments — averaging $752.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$72K
  • Surmodics, Inc.$1K
  • Merz North America, Inc.$548
  • Philips North America LLC$324
  • Veryan Medical Incorporated$294
  • Silk Road Medical, Inc.$289
  • plus $971 from 13 others

What the payments were for

  • Food & beverage$4,3136%
  • Other$71,65394%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$75,965 in reported general payments places this provider in the 95th percentile of 1,706 family providers in Washington.

See all family providers in Washington

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban22$16,059
ClopidogrelClopidogrel Bisulfate72$572

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$136$16,05922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,706 family providers in Washington.

Other family in Renton

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →